These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiovascular effects of amezinium in humans during passive upright tilt in comparison with norfenefrine and dihydroergotamine. Wilsmann K, Neugebauer G, Kessel R, Lang E. Arzneimittelforschung; 1981; 31(9a):1647-52. PubMed ID: 7197979 [Abstract] [Full Text] [Related]
4. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action. Lenke D, Gries J, Kretzschmar R. Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970 [Abstract] [Full Text] [Related]
6. [Hemodynamic effects following bolus administration of different vasopressive agents for blood pressure stabilization during peridural anesthesia]. Müller H, Brähler A, Börner U, Boldt J, Stoyanov M, Hempelmann G. Reg Anaesth; 1985 Jul; 8(3):43-9. PubMed ID: 2863856 [Abstract] [Full Text] [Related]
7. [Isolated modification of the vascular system by vasopressor agents (akrinor, etilefrin, ephedrine, norfenefrine, amezinium) during extracorporeal circulation in man]. Boldt J, Müller H, Börner U, Kling D, Moosdorf R, Hempelmann G. Anaesthesist; 1986 Feb; 35(2):93-8. PubMed ID: 2870661 [Abstract] [Full Text] [Related]
8. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application. Kaumeier S, Kehrhahn OH, Morgenthaler H, Neugebauer G. Arzneimittelforschung; 1981 Feb; 31(9a):1653-7. PubMed ID: 7197980 [Abstract] [Full Text] [Related]
9. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046. Duncker DJ, Haitsma DB, van der Geest IE, Stubenitsky R, van Meegen JR, Man in't Veld AJ, Verdouw PD. Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223 [Abstract] [Full Text] [Related]
10. Pharmacokinetics of amezinium in rat and dog. Traut M, Brode E, Neumann B, Kummer H. Arzneimittelforschung; 1981 Mar; 31(9a):1594-604. PubMed ID: 7197974 [Abstract] [Full Text] [Related]
14. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?]. Günnicker M, Brinkmann M, Freund U, Piotrowski J, Schieffer M, Velser U. Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699 [Abstract] [Full Text] [Related]
15. Pharmacology of amezinium, a novel antihypotensive drug. IV. Biochemical investigations of the mechanism of action. Traut M, Brode E, Hoffmann HD. Arzneimittelforschung; 1981 Dec; 31(9a):1566-74. PubMed ID: 7197971 [Abstract] [Full Text] [Related]
17. Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals. Sundberg S, Antila S, Scheinin H, Häyhä M, Virtanen M, Lehtonen L. Int J Clin Pharmacol Ther; 1998 Dec; 36(12):629-35. PubMed ID: 9876999 [Abstract] [Full Text] [Related]
18. A synopsis of the therapeutic trials of amezinium. Oloff SH. Arzneimittelforschung; 1981 Dec; 31(9a):1657-71. PubMed ID: 7030356 [No Abstract] [Full Text] [Related]